Healthcare provider profile · identity verified

Brian K Scott, MD

Family Practice · ANKENY, IA · NPI 1205820396

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	554	151
Levothyroxine Sodium	Levothyroxine Sodium	388	95
Omeprazole	Omeprazole	231	74
Lisinopril	Lisinopril	196	54
Metoprolol Succinate	Metoprolol Succinate	195	50
Amlodipine Besylate	Amlodipine Besylate	192	52
Pantoprazole Sodium	Pantoprazole Sodium	182	57
Losartan Potassium	Losartan Potassium	175	52
Hydrochlorothiazide	Hydrochlorothiazide	172	45
Rosuvastatin Calcium	Rosuvastatin Calcium	161	51
Simvastatin	Simvastatin	161	47
Metformin Hcl Er	Metformin Hcl	134	41
Pregabalin	Pregabalin	130	37
Tamsulosin Hcl	Tamsulosin Hcl	125	38
Gabapentin	Gabapentin	111	29
Furosemide	Furosemide	108	36
Ozempic	Semaglutide	108	21
Sertraline Hcl	Sertraline Hcl	95	28
Eliquis	Apixaban	92	20
Escitalopram Oxalate	Escitalopram Oxalate	89	29
Trazodone Hcl	Trazodone Hcl	86	29
Alendronate Sodium	Alendronate Sodium	79	23
Metformin Hcl	Metformin Hcl	79	23
Duloxetine Hcl	Duloxetine Hcl	68	19
Potassium Chloride	Potassium Chloride	67	19
Clopidogrel	Clopidogrel Bisulfate	66	20
Zolpidem Tartrate	Zolpidem Tartrate	63	16
Glimepiride	Glimepiride	61	16
Prednisone	Prednisone	60	47
Bupropion Xl	Bupropion Hcl	59	17
Allopurinol	Allopurinol	58	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	14
Clonazepam	Clonazepam	56	11
Metoprolol Tartrate	Metoprolol Tartrate	55	17
Albuterol Sulfate Hfa	Albuterol Sulfate	52	22
Tramadol Hcl	Tramadol Hcl	52	17
Atenolol	Atenolol	51	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	15
Montelukast Sodium	Montelukast Sodium	49	14
Cephalexin	Cephalexin	48	37
Celecoxib	Celecoxib	47	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	46	38
Pravastatin Sodium	Pravastatin Sodium	45	13
Alprazolam	Alprazolam	44	12
Jardiance	Empagliflozin	41	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	13
Tizanidine Hcl	Tizanidine Hcl	40	19
Benazepril Hcl	Benazepril Hcl	39	suppressed
Mirtazapine	Mirtazapine	38	suppressed
Glipizide Er	Glipizide	36	13
Fluticasone Propionate	Fluticasone Propionate	35	11
Lorazepam	Lorazepam	35	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	12
Buspirone Hcl	Buspirone Hcl	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Ezetimibe	Ezetimibe	32	13
Famotidine	Famotidine	31	suppressed
Trospium Chloride	Trospium Chloride	31	suppressed
Finasteride	Finasteride	30	suppressed
Meloxicam	Meloxicam	30	12
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Valsartan	Valsartan	28	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Mounjaro	Tirzepatide	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Azithromycin	Azithromycin	21	17
Carvedilol	Carvedilol	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Ramipril	Ramipril	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Terazosin Hcl	Terazosin Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Synthroid	Levothyroxine Sodium	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Lansoprazole	Lansoprazole	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Trintellix	Vortioxetine Hydrobromide	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Cefdinir	Cefdinir	11	11
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Levofloxacin	Levofloxacin	11	11
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error